Unternehmen
NOVAVAX AB
NOVAVAX AB – Unternehmen mit Aktivitäten in Forschung und Innovation.
Forschungsprojekte
- Optimising a High Efficacy Plasmodium vivax Malaria Vaccine Plasmodium vivax is the most widespread human malaria with 2.5 billion people living at risk in South America…
- A Vaccine Targeting Eradication of Malaria Malaria killed about 640 thousand people in 2020, largely young children in Africa. Rapid recent progress has…